Search
moon
sun
โ›„

T208. Cold Injuries

A. Introduction

A1. Freezing injury

โ€ข
๋™๊ฒฐ์  ๋ฐ‘์˜ ์˜จ๋„ํ™˜๊ฒฝ(below freezing)์—์„œ ๋ฐœ์ƒ * Frostbite(๋™์ƒ) : ์˜๊ตฌ ์กฐ์ง ์†์ƒ

A2. Nonfreezing injury

โ€ข
๋™๊ฒฐ์  ์œ„์˜ ์˜จ๋„(above freezing)์—์„œ ์Šตํ•œ ํ™˜๊ฒฝ ๋…ธ์ถœ ์‹œ ๋ฐœ์ƒ
โ€ข
Freezing injury์— ๋น„ํ•˜์—ฌ mild, inflammation
โ€ข
Trench foot (์ฐธํ˜ธ์กฑ) < Immersion foot (์ฐธ์กฑ๋ณ‘, ์ฐธํ˜ธ์กฑ๋ณด๋‹ค more severe variant)
โ€ข
Chilblain, Pernio (๋™์ฐฝ)
โ€ข
Panniculitis (์ง€๋ฐฉ์ธต์—ผ)
โ€ข
Cold urticaria (ํ•œ๋žญ ๋‘๋“œ๋Ÿฌ๊ธฐ)

B. Nonfreezing cold injuries

B1. Trench foot (์ฐธํ˜ธ์กฑ)

(1) ์ •์˜

โ€ข
๋ฐœ์˜ ํ”ผ๋ถ€๊ฐ€ ํ•˜์–—๊ณ  ์—ฐํ•˜๊ฒŒ ๋ณ€ํ•˜๊ณ  ๋ฐœ๋ฐ”๋‹ฅ ๋ฉด์ด ๊ฐˆ๋ผ์ง€๋ฉด์„œ ๋ถ€์–ด ์˜ค๋ฅด๋Š” ์ฆ์ƒ
โ€ข
๋น„๋™๊ฒฐ ์†์ƒ์˜ ๋Œ€ํ‘œ์ ์ธ ์˜ˆ์ด๋‹ค.

(2) ๋ฐœ์ƒ ๋ณ‘์ธ ๊ธฐ์ „

โ€ข
์ €์˜จ์— ์žฅ์‹œ๊ฐ„ ๋…ธ์ถœ(prolonged cooling)๋กœ ๋ฐœ์ƒํ•˜์—ฌ ์Šต์œค ์ƒํƒœ(wet condition)์— ์˜ํ•ด ์•…ํ™” ๊ฐ€์†
โ€ข
์—ฐ๋ถ€์กฐ์ง์— ์ง์ ‘ ์†์ƒ ์œ ๋ฐœ

(3) ํŠน์ง•

โ€ข
๊ตฐ์ธ์—์„œ ํ”ํ•จ
โ€ข
๋ง์ดˆ ์‹ ๊ฒฝ์ด ๊ฐ€์žฅ ์†์ƒ์— ๋ฏผ๊ฐ

(4) ์ฆ์ƒ ๋ฐ ์ง•ํ›„

โ€ข
Early : Tingling to numbness, pale, mottled, anesthetic (์˜๊ตฌ์ ์œผ๋กœ ๊ฐ€๋Šฅ), pulseless
โ€ข
After rewarming (perfusion) : No immediate change
โ€ข
hyperemic phase (within hrs) : Severe burning pain, ๊ทผ์œ„๋ถ€ ๊ฐ๊ฐํšŒ๋ณต
โ€ข
2~3 days later : Edema, Bullae, Sloughing(๋ถ•๊ดด) or gangrene with severe case Months to years : Hyperhidrosis (๋‹คํ•œ์ฆ), cold sensitivity

(5) ์น˜๋ฃŒ

โ€ข
๋ณด์กด์  ์น˜๋ฃŒ (keep clean, warm, dry, elevation, monitoring infection sign)
โ€ข
Consider vasodilators (Oral prostaglandin : limaprost 20mcg TID) : ํ”ผ๋ถ€ ์˜จ๋„ ์ƒ์Šน, ์ˆœํ™˜ ํ–ฅ์ƒ

(6) ์˜ˆ๋ฐฉ

โ€ข
Keep warm
โ€ข
์‹ ๋ฐœ์ด๋‚˜ ์–‘๋ง์ด ์ –์œผ๋ฉด ๋ฐ”๋กœ ๊ต์ฒด, ์ –์€ ์ฑ„๋กœ ์ž ๋“ค์ง€ ์•Š๊ธฐ

B2. Chilblains or Pernio (๋™์ฐฝ)

(1) ๋ฐœ์ƒ ๋ณ‘์ธ ๊ธฐ์ „

โ€ข
์Šตํ•œ (damp) ๊ฒฝ๋„์˜ ์ €์˜จ(nonfreezing) ํ™˜๊ฒฝ์— ์žฅ์‹œ๊ฐ„ ๊ฐ„ํ—์  ๋…ธ์ถœ์‹œ ๋ฐœ์ƒ
โ€ข
๊ฒฝ๋ฏธํ•˜์ง€๋งŒ ๋ถˆํŽธํ•œ ํ”ผ๋ถ€ ์—ผ์ฆ์„ฑ ๋ฐ˜์‘ ์œ ๋ฐœ
โ€ข
๊ธ‰์„ฑ ์ถ”์œ„ ๋…ธ์ถœ ์‹œ ์ฆ์ƒ ์•…ํ™”

(2) ํŠน์ง• (epidemiology)

โ€ข
์—ฌ์„ฑ๊ณผ ์–ด๋ฆฐ์ด๋“ค / ๋ฐœ(๋ฐœ๊ฐ€๋ฝ), ์†, ๊ท€, ๋‹ค๋ฆฌ์— ํ˜ธ๋ฐœ
โ€ข
์˜๊ตญ๊ณผ ๊ทธ ์™ธ ์˜จ๋Œ€ ๋˜๋Š” ๋ƒ‰๋Œ€์˜ ์Šต์œค ๊ธฐํ›„๋ฅผ ๊ฐ€์ง€๋Š” ๋‚˜๋ผ

(3) ์œ„ํ—˜์š”์ธ

โ€ข
Raynaudโ€™s phenomenon, ์ž๊ฐ€๋ฉด์—ญ์งˆํ™˜ ๋“ฑ ๋ฉด์—ญ ์งˆํ™˜์„ ๊ฐ€์ง„ ์ Š์€ ์—ฌ์„ฑ
โ€ข
์ œ๋Œ€๋กœ ๊ฐ€์˜จ ๋ชปํ•˜๊ณ  ๋”ฐ๋œปํ•˜๊ฒŒ ์ž…์ง€ ๋ชปํ•˜๋Š” ๊ฐ€์ •๋ถ€, ๋‚ฎ์€ BMI

(4) ์ฆ์ƒ

โ€ข
๊ธ‰์„ฑ ๋…ธ์ถœ 12-24์‹œ๊ฐ„ ํ›„ ํ”ผ๋ถ€ ์ฆ์ƒ ๋ฐœ์ƒ
โ€ข
Tingling to numbness, localized edema, erythema, cyanosis, plaque, nodule (Ulcer, vesicle, bullae๋Š” rare), pruritus, burning sensation
โ€ข
After warming : Tender blue nodules (could be persistent for years)

(5) ์น˜๋ฃŒ

โ€ข
๋ณด์กด์  ์น˜๋ฃŒ (Warm, bandage, dry, elevation, smoking cesation)
โ€ข
Nifedipine (CCB) : 10-20mg PO TID
โ€ข
Pentoxifylline (ํ˜ˆ์•ก์ˆœํ™˜๊ฐœ์„ ์ œ) 400mg PO TID
โ€ข
Limaprost (analog of PGE1) : 20mcg PO TID
โ€ข
Topical corticosteroid (0.1% Triamcinolone)

B3. Panniculitis (์ง€๋ฐฉ์ธต์—ผ)

โ€ข
๊ฒฝ๋„์˜ ํ”ผํ•˜์ง€๋ฐฉ์กฐ์ง์˜ ๊ดด์‚ฌ
(1) ์›์ธ : ๋™๊ฒฐ์  ๋ฐ”๋กœ ์œ„์˜ ์˜จ๋„์— ์žฅ์‹œ๊ฐ„ ๋…ธ์ถœ๋˜์–ด ๋ฐœ์ƒ
(2) ์—ญํ•™ : ์†Œ์•„(๋บจ), ์Šน๋งˆ ๋“ฑ์˜ ํ™œ๋™์„ ํ•˜๋Š” ์ Š์€ ์—ฌ์„ฑ์˜ ํ—ˆ๋ฒ…์ง€๋‚˜ ๋‘”๋ถ€
(3) ์˜ˆํ›„ : ์—ผ์ฆ๋ฐ˜์‘์ด ํ•ด์†Œ๋˜๋ฉด์„œ ์ง€๋ฐฉ์กฐ์ง์˜ ์„ฌ์œ ํ™”๋กœ ๋ฏธ์šฉ์ƒ ๊ฒฐ์  ๋ฐœ์ƒ ๊ฐ€๋Šฅ
(4) ์น˜๋ฃŒ : ํšจ๊ณผ์ ์ธ ์น˜๋ฃŒ ๋ฐฉ๋ฒ•์ด ์—†๋‹ค

B4. Cold urticaria (ํ•œ๋žญ ๋‘๋“œ๋Ÿฌ๊ธฐ)

โ€ข
์ฐจ๊ฐ€์šด ๊ณต๊ธฐ์™€ ๋ฌผ์— ๋Œ€ํ•œ ๊ณผ๋ฏผ๋ฐ˜์‘(hypersensitivity), anaphylaxis๋Š” rare
(1) ์›์ธ : Idiopathic(most), IgE + mast cell, viral infection
(2) ์ง„๋‹จ : Cold water test
(3) ์—ญํ•™ : ์ Š์€ ์„ฑ์ธ, ์†Œ์•„, ์•„ํ† ํ”ผ ํ™˜์ž, ๋‹ค๋ฅธ ์œ ๋ฐœ์„ฑ ๋‘๋“œ๋Ÿฌ๊ธฐ ํ™˜์ž
(4) ์น˜๋ฃŒ : ๋‹ค๋ฅธ urticaria์™€ ๋น„์Šท
โ€ข
Antihistamine (H1) : Up to 4 times the standard dose (Caution for CKD) Desloratadine (5mg QD), Loratadine (10mg QD)
โ€ข
Leukotriene receptor antagonists (Zafirlukast, Montelukast)
โ€ข
Topical capsacin
โ€ข
Persistent : Leukotriene receptor antagonists(ketotifen, doxantrazole), Mast cell stabilizers, immunomodulators
โ€ข
h/o anaphylaxis : Epinephrine autoinjector

C. Freezing injuries

โ€ข
๋Œ€ํ‘œ์ ์ธ ์˜ˆ๊ฐ€ frostbite

C1. ์—ญํ•™

(1) ๊ณ ์œ„ํ—˜๊ตฐ : ๊ตฐ์ธ, ๋™๊ณ„์Šคํฌ์ธ  ์„ ์ˆ˜, ์•ผ์™ธ ๋…ธ๋™์ž, ๊ณ ๋ น, ๋…ธ์ˆ™์ž, ์•ฝ๋ฌผ/์•Œ์ฝ”์˜ฌ์ค‘๋…์ž, ์ •์‹ ์งˆํ™˜์ž
(2) ํ˜ธ๋ฐœ ๋ถ€์œ„ : ๋จธ๋ฆฌ (31~39%) > ์†(20~27.9%) > ๋ฐœ (15~24.9%)

C2. ์œ„ํ—˜์š”์ธ

(1) ์„ฑ๋ณ„ : ๋‚จ > ์—ฌ (์—ฌ์„ฑ์ด injury์—๋Š” ๋” ์ทจ์•ฝ)
(2) ์˜จ๋„ ๋ฐ ๊ธฐํ›„
โ€ข
๋ฐ”๋žŒ : 4.5m/s ์ด์ƒ์˜ ํ’์†์—์„œ
โ€ข
๊ณ ๋„ : ๋‚ฎ์€ ๊ธฐ์˜จ๊ณผ ํ•จ๊ป˜ ๋™์ƒ ์œ„ํ—˜ ๋†’์ž„, 5182m ์ด์ƒ
โ€ข
๊ธฐ์˜จ : ์˜ํ•˜ 20๋„ ์ดํ•˜ (ํ”ผ๋ถ€ ์˜จ๋„๊ฐ€ 0๋„ ์ดํ•˜์—์„œ ๋™์ƒ ๋ฐœ์ƒ)
โ€ข
๋…ธ์ถœ์‹œ๊ฐ„ : ๋…ธ์ถœ ๋ฒ”์œ„, ๋ณดํ˜ธ ์žฅ๊ตฌ ์ฐฉ์šฉ, ํ™œ๋™ ์ •๋„์— ๋”ฐ๋ผ ๋‹ค์–‘
(3) ํ–‰๋™, ์ƒ๋ฆฌ์  ์œ„ํ—˜ ์š”์ธ
โ€ข
์Œ์ฃผ, ํก์—ฐ, ๋ถ€์ ์ ˆํ•œ ์˜๋ณต (์žฅ๊ฐ‘, ๋ชจ์ž, ์Šค์นดํ”„, ์ –์€์˜ท), ๊ฝ‰ ๋ผ๋Š” ์˜ท, ๋ถ€๋™ ์ž์„ธ, ๋ณดํ˜ธ์—ฐ๊ณ 
โ€ข
๋‚ฎ์€ ๊ต์œก/์ˆ˜๋ จ ์ˆ˜์ค€, ๋‚ฎ์€ ๊ณ„๊ธ‰, ํ”ผ๋กœ, ์˜์–‘๊ฒฐํ•, ํ‘์ธ, ๊ตฐ์ธ
โ€ข
๋ง์ดˆํ˜ˆ๊ด€์งˆํ™˜, ๋™๋งฅ๊ฒฝํ™”์ฆ, ํ˜ˆ๊ด€์—ผ, vibration induced white finger, ํƒˆ์ˆ˜, ๋‹น๋‡จ, ์™ธ์ƒ/๊ฐ์—ผ์— ์˜ํ•œ ํ˜ˆ๊ด€ ์†์ƒ, ์ด์ „ ํ•œ๋žญ์†์ƒ, Raynaud phenomenon, Cold-induced vasodilation reactivity, ๋ง์ดˆ์‹ ๊ฒฝ์งˆํ™˜, ์˜์‹์ €ํ•˜, ์ •์‹ ์งˆํ™˜ ๋“ฑ
โ€ข
์•ฝ : ํ˜ˆ๊ด€์ˆ˜์ถ•์ œ

C3. Pathophysiology

โ€ข
๋™๊ฒฐ๋งŒ์ด ์•„๋‹ˆ๋ผ ํ•ด๋™๊ณผ์ •๋„ ํ•จ๊ป˜ ์กฐ์ง ์†์ƒ์— ๊ธฐ์—ฌํ•œ๋‹ค. * ์†์ƒ ๊นŠ์ด๋Š” ๋…ธ์ถœ ์˜จ๋„, ๋…ธ์ถœ ์‹œ๊ฐ„, ๋ƒ‰๊ฐ ์†๋„์— ์˜ํ•ด ๊ฒฐ์ •

(1) ํ•ด๋™ ์‹œ์ž‘ ์‹œ์ ์— ๋ฐœ์ƒํ•˜๋Š” ๋‚ดํ”ผ์„ธํฌ์˜ ์†์ƒ์ด ๋™์ƒ์˜ ๊ฒฐ์ •์ ์ธ ์›์ธ

โ†’ Arachidonic acid cascade โ†’ ํ˜ˆ๊ด€ ์ˆ˜์ถ•, ํ˜ˆ์†ŒํŒ ์‘์ง‘, ๋ฐฑํ˜ˆ๊ตฌ ๋ฐ ์ ํ˜ˆ๊ตฌ์˜ ํ˜ˆ๊ด€ ๋‚ด ์ •์ฒด ์ด‰์ง„ โ†’ ์†Œ์ •๋งฅ/๋™๋งฅ ๋‚ด์— ํ˜ˆ์ „ โ†’ Ischemia, necrosis, dry gangrene๋ฅผ ์œ ๋ฐœ

(2) Injury zone

โ€ข
Zone of hyperemia : Most superficial, proximal, least damage (์ผ๋ฐ˜์ ์œผ๋กœ 10์ผ ๋‚ด ํšŒ๋ณต)
โ€ข
Zone of stasis : Middle ground, severe but reversible cell damage
โ€ข
Zone of coagulation : Most severe, distal, irreversible

(3) Susceptibility

Cartilage < Ligament < Blood vessel < Cutis < Epidermis < Bone < Muscle < Nerve < Bone marrow

C4. ์ฆ์ƒ

(1) ๋ถ„๋ฅ˜ (Tintinalli 9th, Ch 208, p1334, Table 208-3)
โ€ข
By depth of injury + amount of tissue damage after rewarming
โ€ข
Tissue viability : Gangrenous tissue ๊ฒฝ๊ณ„ ๋งŒ๋“ค์–ด์ง€๋Š” ์ˆ˜ ์ฃผ ํ›„์— ํ™•์ธ๊ฐ€๋Šฅ
โ€ข
์ฒ˜์Œ์—๋Š” ์†์ƒ ์ •๋„๋ฅผ ํ™•์ธํ•˜๊ธฐ ์–ด๋ ค์›Œ ์ดˆ๊ธฐ ์†์ƒ์œผ๋กœ ๋ถ„๋ฅ˜
โ€ข
๊ฐ€์žฅ ํ”ํ•œ ์ฆ์ƒ์€ ๊ฐ๊ฐ ์ €ํ•˜

C5. ์ง„๋‹จ

(1) Frostbite๋Š” ์ž„์ƒ์ ์œผ๋กœ ์ง„๋‹จํ•˜๋ฉฐ ํŠน๋ณ„ํ•œ ํ˜ˆ์•ก๊ฒ€์‚ฌ๋‚˜ ๋„์›€์ด ๋˜๋Š” ์˜์ƒ ๊ฒ€์‚ฌ๋Š” ์—†๋‹ค.
(2) ํ–ฅํ›„ ์˜ˆํ›„ ๋ฐ ์น˜๋ฃŒ ๋ฐฉํ–ฅ์— ๋„์›€์ด ๋  ์ˆ˜ ์žˆ๋Š” ๊ฒ€์‚ฌ : Tc99-scintigraphy(bone scan), Angiogram

C6. ์น˜๋ฃŒ

(1) ๋ณ‘์› ์ „ ๋‹จ๊ณ„

โ€ข
๋ชฉํ‘œ : ์ถ”๊ฐ€ ํ•œ๋žญ ์†์ƒ, ์ €์ฒด์˜จ, ํƒˆ์ˆ˜ ๋ฐฉ์ง€
โ€ข
์ –๊ณ  ๋ผ๋Š” ์˜๋ณต์„ ์ œ๊ฑฐํ•˜๊ณ  ๋งˆ๋ฅธ ์˜ท์œผ๋กœ ํ™˜์˜ํ•˜์—ฌ ๋ฐ”๋žŒ์œผ๋กœ๋ถ€ํ„ฐ ๋ณดํ˜ธ
โ€ข
๊ฒฝ๋ฏธํ•˜๊ณ  ์˜์‹ ์žˆ๋Š” ๊ฒฝ์šฐ : Warm drinking
โ€ข
ํ™˜๋ถ€์— ์—ด์„ ๊ฐ€ํ•˜์ง€ ์•Š๋Š”๋‹ค. (์ถ”๊ฐ€ ์†์ƒ ๋ฐฉ์ง€)
โ€ข
Refreezing risk๊ฐ€ ์ œ๊ฑฐ๋  ๋•Œ๊นŒ์ง€ ํ•ด๋™์„ ์‹œ๋„ํ•˜์ง€ ์•Š๋Š”๋‹ค. (Refreezing์€ ๋” ์‹ฌ๊ฐํ•œ ์†์ƒ์„ ์œ ๋ฐœ)
โ€ข
์ง„ํ†ต์ œ : Rewarming ๊ณผ์ •์—์„œ ํ†ต์ฆ์ด ์œ ๋ฐœ
โ€ข
์•ˆ์ • ๋ฐ ๊ฑฐ์ƒ (๋ถ€์ข…์ด๋‚˜ ๋ฌผ์ง‘ ์žˆ๋Š” ๋‹ค๋ฆฌ๋กœ ๊ฑท์ง€ ์•Š๋Š”๋‹ค)
โ€ข
๋™์ƒ ๋ถ€์œ„๋ฅผ ๋ˆˆ์œผ๋กœ ๋ฌธ์ง€๋ฅด๊ฑฐ๋‚˜ ๋งˆ์‚ฌ์ง€, ์—ฐ๊ณ  ๋“ฑ์„ ๋ฐ”๋ฅด์ง€ ์•Š๋Š”๋‹ค.

(2) ์‘๊ธ‰์‹ค ์น˜๋ฃŒ (Tintinalli 9th, Ch 208, p1336, Table 208-4)

<Core treatment>
1.
Rapid rewarming : ์ฒซ๋ฒˆ์งธ ๊ฒฐ์ •์  ์น˜๋ฃŒ๋กœ ๊ฐ€๋Šฅํ•œ ๋นจ๋ฆฌ ์‹œํ–‰ํ•ด์•ผ ํ•œ๋‹ค.
โ€ข
์‚ฌ์ง€ : 37~39ยฐC์˜ ํ๋ฅด๋Š”(์ˆœํ™˜๋˜๋Š”) ๋ฌผ๋กœ ์•ฝ 20~30๋ถ„ ์ •๋„ ํ”ผ๋ถ€๊ฐ€ ๋ง๋ž‘๋ง๋ž‘ํ•ด์ง€๊ณ  ๋ถ‰์–ด์งˆ ๋•Œ๊นŒ์ง€ ๋ถ€๋“œ๋Ÿฝ๊ฒŒ ์‹œํ–‰
โ€ข
์–ผ๊ตด : ๋”ฐ๋œปํ•œ ๋ฌผ๋กœ ์ ์‹  ์ˆ˜๊ฑด์œผ๋กœ ๋ˆŒ๋Ÿฌ์ค€๋‹ค.
2.
์ง„ํ†ต์ œ : ํ•ด๋™์œผ๋กœ ์ธํ•œ ์‹ฌํ•œ ํ†ต์ฆ ์‹œ ์ •๋งฅ opiate ํˆฌ์—ฌ
3.
Local care
โ€ข
Clear blister ์ œ๊ฑฐ๊ฐ€ ์กฐ์ง ์†์ƒ ๊ฐ์†Œ ๋ฐ Topical oint ์ ์šฉ์„ ์šฉ์ด์ผ€ ํ•  ์ˆ˜ ์žˆ์œผ๋‚˜ ์ด๊ฒฌ์ด ์žˆ๋‹ค. - Hemorrhagic blister๋Š” ์ œ๊ฑฐํ•˜๋ฉด ์•ˆ๋˜๋ฉฐ (์†์ƒ์ฆ๊ฐ€), aspiration์€ controversial - ์†๋ฐœ๊ฐ€๋ฝ์€ dry cotton, sterile gauze๋กœ ๊ฐ์‹ธ ์„œ๋กœ ๋ถ„๋ฆฌ - ์†๋ฐœ๊ฐ€๋ฝ ์™ธ ๋ถ€์œ„๋Š” ํฌ๊ณ  ํ—๋ ํ•œ(๋ถ€์ข…์ด ๋ฐœ์ƒํ•˜๋Š” ๊ณต๊ฐ„ ํ—ˆ์šฉ) ๋งˆ๋ฅธ ๊ฑฐ์ฆˆ๋กœ ๋ฎ์–ด์ค€๋‹ค.
4. Aloe vera cream q 6hrs : Arachidonic acid cascade์™€ ๊ฒฝ์Ÿํ•˜์—ฌ ์กฐ์ง ์†์ƒ ๊ฐ์†Œ
5. ๊ฑฐ์ƒ
6. Tetanus immunization
7. Ibuprofen 600mg or 10mg/kg/dose q 6hrs, in divided doses
<Optional treatment>
8.
Thrombolysis (IV/IA t-PA)
โ€ข
์•„์ง๋„ ์–ด๋А ์ •๋„ ๋…ผ๋ž€, 8ํŒ์— ๋น„ํ•ด 9ํŒ์—์„œ๋Š” multiple expert recommendation
โ€ข
Tissue injury d/t microvascular thrombosis - Rapid rewarming 24์‹œ๊ฐ„ ์ด๋‚ด์— ์ฃผ๊ฒŒ ๋˜๋Š” ๊ฒฝ์šฐ amputation riskโ†“ - ๋ฌผ๋ก , bleeding risk ๊ณ ๋ ค - 0.15 mg/kg bolus +0.15mg/kg infusion over 6hrs + heparin 24-72hrs
9. Vasodilators : Prostacycline (Iloprost) IV - 0.5 ng/kg/min for 5 days
10. ๋…ผ๋ž€ ์ค‘์ธ ์น˜๋ฃŒ
โ€ข
์˜ˆ๋ฐฉ์  ํ•ญ์ƒ์ œ : IV penicillin G, 500,000 u q 6hrs for 48-72 hours /
โ€ข
Topical antibiotics(bacitracin, silver sulfadiazine cream): not currently recommended
โ€ข
Sympathetic blockade for vasospasm, edema : IA reserpine, sympathectomy - Heparinization, HBOT - ์กฐ๊ธฐ ์ˆ˜์ˆ ์  ์น˜๋ฃŒ๋Š” ๊ถŒ์žฅ๋˜์ง€ ์•Š๋Š”๋‹ค. (fasciotomy๋Š” ํ•„์š” ์‹œ ํ•˜์ง€๋งŒ rare)

C7. ํ›„์œ ์ฆ

โ€ข
65%๊ฐ€ ๊ฒฝํ—˜
โ€ข
๋Œ€๋ถ€๋ถ„ ์ถ”์œ„์— ๋Œ€ํ•œ ๋ฏผ๊ฐ์„ฑ, ํ†ต์ฆ, ์ €๋ฆฐ๊ฐ, ์‹ ๊ฒฝํ†ต

C8. Disposition & follow-up

โ€ข
์‚ฌํšŒ๊ฒฝ์ œ์ ์œผ๋กœ ํ‡ด์›ํ•ด์„œ ๋‹ค์‹œ ์ถ”์œ„์— ๋…ธ์ถœ๋  ์ˆ˜ ์žˆ๋Š” ๊ณ ๋ น, ๋…ธ์ˆ™์ž๋“ค์€ ํ‡ด์›์‹œํ‚ค๋ฉด ์•ˆ๋œ๋‹ค. ์ฆ‰ ํ‡ด์› ์‹œ ์—ฐ๋ น, ๊ธฐ์ €์งˆํ™˜, ์‚ฌํšŒ๊ฒฝ์ œ์  ๊ณ ๋ ค ํ•„์š”
โ€ข
ํ™”์ƒ์„ผํ„ฐ๋‚˜ ์„ฑํ˜•์™ธ๊ณผ ๋ณ‘์›์œผ๋กœ F/U
โ€ข
ํ‡ด์› ์‹œ topical aloe vera๋‚˜ PO ibuprofen ์ฒ˜๋ฐฉ ํ•„์š”
โ€ข
๊ธˆ์—ฐ, ๊ธˆ์ฃผ ๊ต์œก